REPORTS

Let’s Pullulate and Expand Your Business

Dengue Vaccines Market - Global Professional Analysis and Forecast to 2026

Mar 28, 2020  |  173 PAGES  |  REPORT CODE: CMM274295
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Dengue Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.4% during the forecast period.

This report presents the market size and development trends by detailing the Dengue Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Dengue Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Dengue Vaccines industry and will help you to build a panoramic view of the industrial development.

Dengue Vaccines Market, By Type:

  • CYD-TDV

  • Tak-003

  • Other

Dengue Vaccines Market, By Application:

  • Hospitals

  • Government Institutes

  • Non-Governmental Organizations (NGOs)

Some of the leading players are as follows:

  • Takeda Pharmaceutical

  • Sanofi

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Dengue Vaccines Market: Technology Type Analysis

  • 4.1 Dengue Vaccines Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Dengue Vaccines Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 CYD-TDV

    • 4.3.2 Tak-003

    • 4.3.3 Other

5 Dengue Vaccines Market: Product Analysis

  • 5.1 Dengue Vaccines Product Market Share Analysis, 2018 & 2026

  • 5.2 Dengue Vaccines Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Dengue Vaccines Market: Application Analysis

  • 6.1 Dengue Vaccines Application Market Share Analysis, 2018 & 2026

  • 6.2 Dengue Vaccines Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospitals

    • 6.3.2 Government Institutes

    • 6.3.3 Non-Governmental Organizations (NGOs)

7 Dengue Vaccines Market: Regional Analysis

  • 7.1 Dengue Vaccines Regional Market Share Analysis, 2018 & 2026

  • 7.2 Dengue Vaccines Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Takeda Pharmaceutical

    • 9.1.1 Takeda Pharmaceutical Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Sanofi

    • 9.2.1 Sanofi Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

 

The List of Tables and Figures (Totals 112 Figures and 150 Tables)

  • Figure CYD-TDV Dengue Vaccines market, 2015 - 2026 (USD Million)

  • Figure Tak-003 Dengue Vaccines market, 2015 - 2026 (USD Million)

  • Figure Other Dengue Vaccines market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Figure Government Institutes market, 2015 - 2026 (USD Million)

  • Figure Non-Governmental Organizations (NGOs) market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Dengue Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table North America Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table North America Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table North America Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Canada Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Canada Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Europe Dengue Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Europe Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Europe Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Europe Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Germany Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Germany Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table France Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table France Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Italy Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Italy Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Spain Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Spain Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dengue Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table China Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table China Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Japan Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Japan Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table India Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table India Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Dengue Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table MEA Dengue Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table MEA Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table MEA Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table MEA Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Dengue Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Dengue Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Dengue Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Takeda Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top